Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07207902 · ClinicalTrials.gov registry record · NA

Surveillance or Focal Therapy

A NA study of Prostate Cancer, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT07207902 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 400 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07207902, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Patients with newly diagnosed low-intermediate risk prostate cancer often are not advised of all the options in an easy to understand way. This trial will show patients a 2 minute animated Explainer video to better understand their treatment options. Patients will choose their treatment choice (surveillance, focal therapy, or standard treatment option) and we will determine disease related anxiety and decision regret scores.

Conditions Studied

Interventions

  • BEHAVIORAL Explainer video

Study Locations (1)

California

  • Kaiser Permanente - Los Angeles

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-06-01
Est. Completion 2026-12-01
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT07207902

The ClinicalTrials.gov registry entry for NCT07207902 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (34% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Explainer video is the first listed.

NCT07207902 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07207902 about?

NCT07207902 is a clinical study titled "Surveillance or Focal Therapy". Patients with newly diagnosed low-intermediate risk prostate cancer often are not advised of all the options in an easy to understand way. This trial will show patients a 2 minute animated Explainer video to better understand their treatment options. Patients will choose their treatment choice (surv...

What is the current status of trial NCT07207902?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-06-01. Estimated completion is 2026-12-01.

What conditions does trial NCT07207902 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT07207902?

The interventions under investigation include: Explainer video (BEHAVIORAL).

Who is sponsoring clinical trial NCT07207902?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07207902 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.